a memory T-cell booster to enhance the efficacy and long-term immunity of SARS-CoV-2 vaccines

Grant number: 47189.1 IP-LS

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $175,969.6
  • Funder

    Innosuisse
  • Principal Investigator

    Pedro Romero
  • Research Location

    Switzerland
  • Lead Research Institution

    University of Lausanne - LA
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

This project aims to develop an orally administered memory T-cell booster for SARS-CoV-2 vaccines to provide faster & longer protection with less vaccine material. This solution could alleviate manufacturing bottlenecks ultimately accelerating the pace of immunization at the global scale.